A Biography of the Sea. The story of the world ocean, its animal and plant populations, and its influence on human history R. Carrington

Publikováno v: Geography, 1962 Jan 01. 47(1), 116-116.

Externí odkaz: https://www.jstor.org/stable/40565655

The Living World of Animals L. H. Matthews R. Carrington

Autor: Hoffmann, Robert S.

Publikováno v: Journal of Mammalogy, 1971 Aug 01. 52(3), 648-648.

Externí odkaz: https://www.jstor.org/stable/1378618

User stories as lightweight requirements for agile clinical decision support development

Autor: Brett A Moran, Puneet Bajaj, Luis E Saldana, Emily L Flahaven, Seth M. Toomay, Josh E. Youngblood, Vaishnavi Kannan, Tsedey Melaku, Richard J. Medford, Duwayne L Willett, Angela R. Carrington, Mujeeb A. Basit, Irma B Donahue

Publikováno v: Journal of the American Medical Informatics Association : JAMIA

ObjectiveWe sought to demonstrate applicability of user stories, progressively elaborated by testable acceptance criteria, as lightweight requirements for agile development of clinical decision support (CDS).Materials and MethodsUser stories employed

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a3b9e7dd7a8c266de8dfd2b37cdc5fc
https://doi.org/10.1093/jamia/ocz123

Investigation into the Effect of Gender in a Murine Model of Chronic Airway Colonisation with Aspergillus Fumigatus

Autor: A. Smith, P. Kennard, R. Carrington, D. Rogers, D. Bell, L. Haste, S. Jordan

Publikováno v: D34. INFECTIONS AND THE IMMUNE RESPONSE.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4eaab50cbd02a53276cebea93840927f
https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a6524

Use of animal models in IPF research

Autor: Simon C. Pitchford, S. Jordan, R. Carrington, Clive P. Page

Publikováno v: Carrington, R, Jordan, S, Pitchford, S C & Page, C P 2018, ' Use of animal models in IPF research ', PULMONARY PHARMACOLOGY AND THERAPEUTICS, vol. 51, pp. 73-78 . https://doi.org/10.1016/j.pupt.2018.07.002

Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease with a poor prognosis and limited treatment options. Many compounds have shown efficacy in preclinical models of this condition, but only pirfenidone and nintedanib have been ap

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08c06b86be4d204653062ef167830f94
https://doi.org/10.1016/j.pupt.2018.07.002